Provided by Tiger Trade Technology Pte. Ltd.

ANI Pharmaceuticals

70.19
-1.2700-1.78%
Post-market: 70.190.00000.00%16:10 EDT
Volume:329.19K
Turnover:23.20M
Market Cap:1.61B
PE:15.46
High:71.92
Open:71.53
Low:69.58
Close:71.46
52wk High:99.39
52wk Low:69.58
Shares:22.97M
Float Shares:20.28M
Volume Ratio:1.23
T/O Rate:1.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.54
EPS(LYR):3.32
ROE:20.46%
ROA:5.45%
PB:2.70
PE(LYR):21.14

Loading ...

ANI Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Sector Update: Healthcare Stocks Steady Pre-Bell Friday

MT Newswires Live
·
May 08

Update: ANI Pharmaceuticals Q1 Adjusted Earnings, Revenue Rise; Lifts 2026 Outlook

MT Newswires Live
·
May 08

GUIDANCE: (ANIP) ANI Pharmaceuticals Expects 2026 Adjusted EPS Range $9.19 to $9.69, vs. FactSet Est of $9.07

MT Newswires Live
·
May 08

Stock Track | ANI Pharmaceuticals Soars 5.35% in Pre-market on Strong Earnings Beat, Raised Guidance and $100M Buyback

Stock Track
·
May 08

ANI Pharma Q1 FY26 net income rises 93.1% to USD 29.5 million; revenue increases 20.5% to USD 237.5 million

Reuters
·
May 08

BRIEF-ANI Pharmaceuticals Q1 Adjusted EPS USD 2.05 Vs. IBES Estimate USD 1.3

Reuters
·
May 08

ANI Pharmaceuticals Q1 EPS USD 1.28

THOMSON REUTERS
·
May 08

ANI Pharmaceuticals Q1 Adjusted Ebitda USD 63 Million

THOMSON REUTERS
·
May 08

ANI Pharmaceuticals Inc: $100 Mln Share Repurchase Program Authorized by Board of Directors

THOMSON REUTERS
·
May 08

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

THOMSON REUTERS
·
May 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 08

Earning Preview: ANI Pharmaceuticals this quarter’s revenue is expected to increase by 14.88%, and institutional views are bullish

Earnings Agent
·
May 01

ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET

GlobeNewswire
·
Apr 24

ANI Pharmaceuticals Secures FDA Approval for Generic Orap

MT Newswires Live
·
Apr 20

ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity

GlobeNewswire
·
Apr 20

Assessing ANI Pharmaceuticals (ANIP) Valuation After Recent Mixed Share Price Performance

Simply Wall St.
·
Apr 18

ANI Pharma General Counsel Meredith Cook disposes 500 common shares worth $38,975

Reuters
·
Apr 14

BUZZ-U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune

Reuters
·
Apr 14

BUZZ-U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma

Reuters
·
Apr 13